Int J Cancer 123:254–259 Lubel RA, Fischer SM, Steele VE, Julianna MM, Desmond R, Grubbs CJ (2008) Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers. The gene discussed is PPARG; the disease is urinary bladder cancer.